We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Luteolin, a bioflavonoid inhibits azoxymethane-induced colon carcinogenesis: Involvement of iNOS and COX-2.
- Authors
Kumar Pandurangan, Ashok; Ananda Sadagopan, Suresh Kumar; Dharmalingam, Prakash; Ganapasam, Sudhandiran
- Abstract
Colon cancer (CRC) is a serious health problem through worldwide. Development of novel drug without side effect for this cancer was crucial. Luteolin (LUT), a bioflavonoid has many beneficial effects such as antioxidant, anti-inflammatory, anti-proliferative properties. Azoxymethane (AOM), a derivative of 1, 2-Dimethyl hydrazine (DMH) was used for the induction of CRC in Balb/C mice. CRC was induced by intraperitoneal injection of AOM to mice at the dose of 15 mg/ body kg weight for 3 weeks. Mouse was treated with LUT at the dose of 1.2 mg/body kg weight orally until end of the experiment. The expression of inducible nitric oxide synthase (iNOS) and cyclooxygense (COX)-2 were analyzed by RT-PCR and immunohistochemistry. The expressions of iNOS and COX-2 were increased in the case of AOM induction. Administration of LUT effectively reduced the expressions of iNOS and COX-2. The present study revealed that, LUT suppresses both iNOS and COX-2 expressions and act as an anti-inflammatory role against CRC.
- Subjects
BIOFLAVONOIDS; LUTEOLIN; COLON cancer; CARCINOGENESIS; ANTIOXIDANTS; ANTI-inflammatory agents
- Publication
Pharmacognosy Magazine, 2014, Vol 10, Issue 38/S2, pS306
- ISSN
0973-1296
- Publication type
Article
- DOI
10.4103/0973-1296.133285